Generic filters
Exact matches only
Search in title
Search in content
Search in excerpt

QPS

QPS Now Has Exclusive Distribution Rights for Samsara’s Specialized Human Liver Cells

Bioanalytical Services /

QPS and Samsara Sciences have solidified a cell supply partnership for the production, characterization and distribution of primary human liver cells including hepatocytes and hepatic stellate cells for research. QPS now has exclusive rights to distribute Samsara’s primary human hepatocytes. At the same time, the two companies will also cooperate to provide specialized non-parenchymal hepatocytes […]

QPS Now Has Exclusive Distribution Rights for Samsara’s Specialized Human Liver Cells Read More »

QPS Global Clinical Operations Team Aces Enrollment for Global Study of Prostate Cancer Drug and Completes the First Patient in Europe!

Clinical Trials /

QPS has been assisting an international Sponsor to perform a global, late-phase study to investigate the safety, efficacy, and pharmacokinetic behavior of a newly formulated investigational drug in subjects with advanced prostate carcinoma. The original enrollment goal was 133 patients to be enrolled in approximately 18 months. The QPS Global Clinical Operations team enrolled 137

QPS Global Clinical Operations Team Aces Enrollment for Global Study of Prostate Cancer Drug and Completes the First Patient in Europe! Read More »

QPS will create an (LC)-ICP-MS assay to perform the critical elemental analysis in your drug development study

Bioanalytical Services /

If you need to quantify blood zinc levels, are working on a gadolinium-based MRI contrast agent, or need to measure platinum levels in mouse livers – a QPS-developed (LC)-ICP-MS assay may well be what you need. These assays, validated according to FDA, EMA and ICH guidelines, can quantify levels of most ELEMENTS (such as iron,

QPS will create an (LC)-ICP-MS assay to perform the critical elemental analysis in your drug development study Read More »

Consultation open on revised EMA Guideline on Medicines to treat Alzheimer’s Disease

Clinical Trials /

The European Medicines Agency (EMA) has released a draft guideline revision on the clinical investigation of medicines for the treatment of Alzheimer’s disease and other dementias for a six-month public consultation. The EMA considers dementia a key public health priority and sees early stage intervention and prevention of symptomatic disease as particularly worthy goals. This

Consultation open on revised EMA Guideline on Medicines to treat Alzheimer’s Disease Read More »

Magnesium-Tablet-Form

New ICP-MS Magnesium (Mg) Assays in Human Plasma and Urine added to the QPS Global Assay Database

Bioanalytical Services /

The role of Mg in human nutrition has recently received renewed interest. Mg dietary intake has been reported to have decreased during the last 100 years in Western countries. For example, in the US it is often below the recommended dietary allowances. Decreased Mg intake and/or low serum Mg have been associated with a number

New ICP-MS Magnesium (Mg) Assays in Human Plasma and Urine added to the QPS Global Assay Database Read More »

See QPS in London at Informa’s Early Clinical Development Conference, 23 – 24 February 2016

Conferences /

On February 23, Professor Zuzana Diamant, MD PhD, Director of Respiratory & Allergy Research at QPS, will talk about Biomarkers in Respiratory Drug Development and personalized medicine at the Informa-sponsored Early Clinical Development conference, Amba Hotel Marble Arch, London. In her lecture, Professor Diamant will cover the following topics: Definition of a valuable biomarker Which

See QPS in London at Informa’s Early Clinical Development Conference, 23 – 24 February 2016 Read More »

Read the QPS Whitepaper on Phase I Site Selection to support EU Registration

Clinical Trials /

Making the right decision about where to conduct Phase I of a clinical trial is crucial. As long as basic EU regulatory requirements are fulfilled, the investigational site may be located anywhere in the world. This paper will walk you through the three key essential considerations for clinical trials intended to support registration in the

Read the QPS Whitepaper on Phase I Site Selection to support EU Registration Read More »

Wishing You a Very Happy New Year, With Some Very Cool Science

News /

Cancer immuno therapies. Oligo therapeutics. CAR T-cell therapies. Breakthrough Antivirals. For the past 20 years, we’ve been following the path of solid science and it’s lead us to this point: about to close out another year spent partnering with the world’s best pharmaceutical and biotech companies in pursuit of better solutions for patients. As our

Wishing You a Very Happy New Year, With Some Very Cool Science Read More »

Growth and Goals-Our Next 10 Years: QPS 20th Anniversary Series, Part 6

News /

The past 20 years for QPS have included countless hours of hard work, exciting change and a tireless commitment to do what is right for the client and the patient. Like anything, there have been ups and downs and challenges to overcome. There have also been accolades and—above all—a transcendent atmosphere of teamwork. And, according

Growth and Goals-Our Next 10 Years: QPS 20th Anniversary Series, Part 6 Read More »

Time is of the essence in Drug Development.

Contact the QPS Business Development Team Today!

Your link to a rewarding career.

Join the QPS team and be part of our growing organization.

Submit Your Resume

About qps

Preclinical Services

Clinical Services

Resources

Headquarters Location

Delaware Technology Park,
3 Innovation Way,
Newark, DE 19711

Connect with us

Linkedin-in Youtube Facebook-f Instagram
download-ios
download-google
qps-assay-finder-black
Copyright © 2024 · QPS Holdings. All Rights Reserved
Scroll to Top